Cargando…
Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754454/ https://www.ncbi.nlm.nih.gov/pubmed/35032591 http://dx.doi.org/10.1053/j.ajkd.2022.01.001 |
_version_ | 1784632275368935424 |
---|---|
author | Fishbane, Steven Hirsch, Jamie S. Nair, Vinay |
author_facet | Fishbane, Steven Hirsch, Jamie S. Nair, Vinay |
author_sort | Fishbane, Steven |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8754454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | by the National Kidney Foundation, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87544542022-01-13 Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection Fishbane, Steven Hirsch, Jamie S. Nair, Vinay Am J Kidney Dis Editorial by the National Kidney Foundation, Inc. 2022-04 2022-01-12 /pmc/articles/PMC8754454/ /pubmed/35032591 http://dx.doi.org/10.1053/j.ajkd.2022.01.001 Text en © 2022 by the National Kidney Foundation, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Fishbane, Steven Hirsch, Jamie S. Nair, Vinay Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection |
title | Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection |
title_full | Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection |
title_fullStr | Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection |
title_full_unstemmed | Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection |
title_short | Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection |
title_sort | special considerations for paxlovid treatment among transplant recipients with sars-cov-2 infection |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754454/ https://www.ncbi.nlm.nih.gov/pubmed/35032591 http://dx.doi.org/10.1053/j.ajkd.2022.01.001 |
work_keys_str_mv | AT fishbanesteven specialconsiderationsforpaxlovidtreatmentamongtransplantrecipientswithsarscov2infection AT hirschjamies specialconsiderationsforpaxlovidtreatmentamongtransplantrecipientswithsarscov2infection AT nairvinay specialconsiderationsforpaxlovidtreatmentamongtransplantrecipientswithsarscov2infection |